manilatimes3m
Alpro Pharmacy and OMRON Healthcare Unite to Combat Fake BP Monitors
(From left: Ph. Wong Wen Jun (Procurement Director of Alpro Pharmacy), Ph. Anson Tan (Category Manager of Alpro Pharmacy), ...
FDA Approves LEQEMBI® (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease
Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatmentAlzheimer's disease progression does ...
Biogen Inc.: FDA Approves LEQEMBI (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease
Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatment Alzheimer's disease progression does not stop after plaque clearance; ongoing treatment with ...